Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
1.990
-0.040 (-1.97%)
At close: Jul 25, 2025, 4:00 PM
2.099
+0.109 (5.48%)
After-hours: Jul 25, 2025, 7:59 PM EDT
Scienture Holdings Employees
As of December 31, 2024, Scienture Holdings had 19 total employees, including 14 full-time and 5 part-time employees. The number of employees did not change compared to the previous year.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$7,732
Profits / Employee
-$802,328
Market Cap
26.10M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19 | 0 | - |
| Dec 31, 2023 | 19 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SCNX News
- 2 days ago - Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding - GlobeNewsWire
- 10 days ago - Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 5 weeks ago - Scienture Holdings Announces Cancelation of ELOC - GlobeNewsWire
- 2 months ago - Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - Accesswire
- 2 months ago - SCIENTURE Announces Executive Leadership Transition - GlobeNewsWire
- 2 months ago - SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL. - GlobeNewsWire
- 3 months ago - SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025. - GlobeNewsWire
- 3 months ago - SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC. - GlobeNewsWire